Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 78

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 78
---
 its network. In its experience, moreover, clients of fertility
treatments tend to be more demanding on the medical services received. In addition, the relevant laws governing medical disputes and claims
grant claimants liberal rights in bringing claims against physicians and other medical professionals practicing in the jurisdiction. As
a result, the medical facilities in its network may be subject to medical disputes and claims arising under relevant laws, from time to
time, which could generate substantial damages imposed on such facilities if not covered by professional liability insurance. Any dispute
with its patients and/or their families or the medical professionals, including those from outside its network, or any legal proceeding
involving the physicians of the medical facilities or medical professionals, including those from outside its network, regardless of its
merit or eventual outcome, could result in significant legal costs and reputational damage to the medical facilities and materially and
adversely affect the business, financial condition and results of operations of the medical facilities in its network, and further affect
its business, financial condition and results of operations.

The assisted reproductive medical facilities in NewGenIvf’s network have limited control over the quality of the pharmaceuticals, medical equipment, medical consumables and other supplies used in its operations, and cannot guarantee that the products in use are not defective or counterfeit. NewGenIvf also has no control over independent sub-contractors and cannot guarantee the services thereof.

The assisted reproductive
medical facilities in NewGenIvf’s network procure a variety of pharmaceuticals, medical equipment, consumables and other supplies
in NewGenIvf’s operations from third-party suppliers. As the medical facilities in NewGenIvf’s network do not engage in the
direct manufacture of such supplies, NewGenIvf cannot assure you that such supplies are free of defects and meet relevant quality standards
or, in the case of imported supplies, verify the origin of such products. In addition, there may be counterfeit pharmaceutical products
manufactured without proper licenses or approvals or fraudulently mislabeled with respect to their content or manufacturer in the pharmaceutical
markets. In some cases these products are very similar in appearance to the authentic products. The quality control checks and processes
may not be able to identify all counterfeit pharmaceutical products in the inventory. Any sale of such products by the medical facilities
in NewGenIvf’s network, regardless of its knowledge as to their authenticity, may subject the medical facilities to administrative
sanctions, civil claims, negative publicity or reputational damage. NewGenIvf